Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account
A A A

Fidelity American Special Situations Fund research update

Kate Marshall | Wed 25 February 2015

Investments can go down as well as up so there is always a danger that you could get back less than you invest. Nothing here is personalised advice, if unsure you should seek advice.

Angel Agudo, manager of the Fidelity American Special Situations Fund, is confident in continued improvements in the US economy. He is encouraged by its improving employment outlook, a pick-up in consumer sentiment, and a narrowing current account deficit (when a country imports more than it exports).

That said, he acknowledges valuations in the US are no longer as attractive as they were previously, following a strong run its stock markets over the past few years. In this environment he suggests it is more challenging to unearth pockets of value. However, he believes recent increased market volatility, a precipitous decline in energy prices and the negative impact of a stronger dollar on overseas earnings has the potential to create new investment opportunities.

At present, the fund has significant exposure to the technology, healthcare and consumer sectors - this is a function of where Angel Agudo finds individual investment opportunities, rather than any strong view on these sectors as a whole.

Within technology, where 21.5% of the fund is invested, the manager has focused on out-of-favour companies with more established business models and products he believes would prove difficult to replicate by competitors. The fund currently holds a position in Oracle, a provider of computer software and hardware products. Despite recent earnings disappointment, Angel Agudo believes improving sales force productivity could lead to acceleration in the take-up of the company's software licenses. This could, in turn, see revenues improve against the expectations of other investors.

20.5% of the portfolio is invested in the healthcare sector. The manager has invested in a number of pharmaceutical firms he believes have underappreciated drug pipelines, as well as service providers - such as Express Scripts - which stand to benefit from healthcare reform and an ageing population.

Conversely, the fund has no exposure to utilities businesses and has tended to avoid other sectors such as financials and energy. Limited exposure to energy-related businesses proved particularly beneficial last year as these firms struggled to perform against a backdrop of falling oil prices.

Register for free fund research by email

Our view on this fund

Since assuming responsibility for the fund in December 2012, Angel Agudo has made a respectable start. The fund has returned 66.8% compared with a benchmark return of 58.8% and 52.1%* for the average fund in the sector. Please remember past performance serves as no guide to future returns.

Annual percentage growth
Feb 10 -
Feb 11
Feb 11 -
Feb 12
Feb 12 -
Feb 13
Feb 13 -
Feb 14
Feb 14 -
Feb 15
Fidelity American Special Situations 20.6% 0.6% 17.4% 19.9% 28.6%
S&P 500 20.6% 5.4% 17.7% 13.3% 28.6%
IMA North America 19.7% 2.4% 14.6% 17.1% 20.5%

Past performance is not a guide to future returns. Source: Lipper IM* to 02/02/2015

We like the manager's approach of aiming to identify undervalued companies, but where he sees positive change on the horizon yet to be noticed by other investors. His focus lies on companies with strong balance sheets and resilient business models, meaning further downside could be limited, though there are no guarantees. That said, his track record remains short and we would like to see how the fund performs over a prolonged period before considering the fund for inclusion on the Wealth 150 list of our favourite funds across the major sectors.

Find out more about this fund including how to invest

Please read the key features/key investor information document in addition to the information above.

The value of investments can go down as well as up, this means you could get back less than you invested. Therefore all investments should be regarded with a long term view. No news or research item is a personal recommendation to deal. If you are unsure about the suitability of an investment please contact us for advice.
Important information - Please remember the value of investments, and any income from them, can fall as well as rise so you could get back less than you invest. This article is provided to help you make your own investment decisions, it is not advice. If you are unsure of the suitability of an investment for your circumstances please seek advice. No news or research item is a personal recommendation to deal.


You may also be interested in: